DEVELOPMENT OF NOVEL TRANSDERMAL SYSTEM CONTAINING D-LIMONENE AND ETHANOL AS ABSORPTION ENHANCERS

被引:20
作者
OKABE, H [1 ]
SUZUKI, E [1 ]
SAITOH, T [1 ]
TAKAYAMA, K [1 ]
NAGAI, T [1 ]
机构
[1] HOSHI UNIV, DEPT PHARMACEUT, SHINAGAWA KU, TOKYO 142, JAPAN
关键词
PERCUTANEOUS ABSORPTION; NOVEL TRANSDERMAL SYSTEM; ETHANOL PERMEATION; RARE-LIMITING MEMBRANE; D-LIMONENE;
D O I
10.1016/0168-3659(94)90234-8
中图分类号
O6 [化学];
学科分类号
0703 [化学];
摘要
The controlled release of ethanol from a reservoir in the transdermal system was studied in order to ensure continuous drug permeation across the skin. The permeation of ethanol through various polymeric membranes was evaluated. The release rate of ethanol was fairly controlled when the membrane was prepared from the ethylmethacrylate-hydroxyethylmethacrylate copolymer (EMA-HEMA). The transdermal system containing indomethacin (IMC) as a model drug, and d-limonene and ethanol as absorption enhancers was newly developed employing the EMA-HEMA membrane. In vitro permeation of IMC through the rat abdominal skin in the system was investigated. The constant flux of IMC was attained by the control of ethanol permeation from the system during the permeation experiment.
引用
收藏
页码:243 / 247
页数:5
相关论文
共 18 条
[1]
BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
[2]
EFFECT OF PENETRATION ENHANCERS ON THE PERMEATION OF MANNITOL, HYDROCORTISONE AND PROGESTERONE THROUGH HUMAN-SKIN [J].
BARRY, BW ;
BENNETT, SL .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (07) :535-546
[3]
INCREASED SKIN PERMEABILITY FOR LIPOPHILIC MOLECULES [J].
COOPER, ER .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1984, 73 (08) :1153-1156
[4]
EBERT C D, 1987, Journal of Controlled Release, V6, P107, DOI 10.1016/0168-3659(87)90068-X
[5]
GHANEM A-H, 1987, Journal of Controlled Release, V6, P75, DOI 10.1016/0168-3659(87)90065-4
[6]
EFFECT OF D-LIMONENE ON THE AMOUNTS OF ETHANOL AND INDOMETHACIN PENETRATED FROM AQUEOUS GEL OINTMENTS TO RAT SKIN [J].
KIKUCHI, K ;
TAKAYAMA, K ;
NAGAI, T .
CHEMICAL & PHARMACEUTICAL BULLETIN, 1992, 40 (11) :3108-3109
[7]
KNEPP VM, 1987, CRC CR REV THER DRUG, V4, P13
[8]
KOKUBO T, 1991, J CONTROL RELEASE, V17, P69
[9]
Merritt EW, 1984, J CONTROL REL, V1, P161
[10]
MUSOLF MC, 1987, TRANSDERMAL CONTROLL, P93